Circulating Tumor Cells (CTCs): A Potential Screening Test for Clinically Undetectable Breast Carcinoma
Last updated on April 2022Recruitment
- Recruitment Status
- Recruiting
Inclusion Criteria
- Military healthcare beneficiary
- Present to the CBCP and willing to be followed at the CBCP during the course of treatment and follow-up
- Adults 18 years of age or older
- ...
- Military healthcare beneficiary
- Present to the CBCP and willing to be followed at the CBCP during the course of treatment and follow-up
- Adults 18 years of age or older
- Undergoing a diagnostic or therapeutic procedure (biopsy, lumpectomy, mastectomy) in the breast clinic or operating room.
- Mentally competent and willing to provide written informed consent prior to entering the study
Exclusion Criteria
- Participants with known human immunodeficiency virus (HIV), any history of hepatitis, prion-mediated disease, drug resistant tuberculosis or other infectious disease presenting a significant risk to personnel handling tissue or blood-derived products shall be excluded from participation
- Participants with pre-existing coagulopathies or all other conditions, for whom invasive biopsy or surgery is medically contraindicated
- Prior history of invasive carcinoma
- ...
- Participants with known human immunodeficiency virus (HIV), any history of hepatitis, prion-mediated disease, drug resistant tuberculosis or other infectious disease presenting a significant risk to personnel handling tissue or blood-derived products shall be excluded from participation
- Participants with pre-existing coagulopathies or all other conditions, for whom invasive biopsy or surgery is medically contraindicated
- Prior history of invasive carcinoma
- Presence of clinically-apparent metastatic disease
Summary
- Conditions
- Breast Abnormality
- Type
- Observational
- Design
- Observational Model: Cohort
- Time Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Inclusion Criteria
- Military healthcare beneficiary
- Present to the CBCP and willing to be followed at the CBCP during the course of treatment and follow-up
- Adults 18 years of age or older
- ...
- Military healthcare beneficiary
- Present to the CBCP and willing to be followed at the CBCP during the course of treatment and follow-up
- Adults 18 years of age or older
- Undergoing a diagnostic or therapeutic procedure (biopsy, lumpectomy, mastectomy) in the breast clinic or operating room.
- Mentally competent and willing to provide written informed consent prior to entering the study
Exclusion Criteria
- Participants with known human immunodeficiency virus (HIV), any history of hepatitis, prion-mediated disease, drug resistant tuberculosis or other infectious disease presenting a significant risk to personnel handling tissue or blood-derived products shall be excluded from participation
- Participants with pre-existing coagulopathies or all other conditions, for whom invasive biopsy or surgery is medically contraindicated
- Prior history of invasive carcinoma
- ...
- Participants with known human immunodeficiency virus (HIV), any history of hepatitis, prion-mediated disease, drug resistant tuberculosis or other infectious disease presenting a significant risk to personnel handling tissue or blood-derived products shall be excluded from participation
- Participants with pre-existing coagulopathies or all other conditions, for whom invasive biopsy or surgery is medically contraindicated
- Prior history of invasive carcinoma
- Presence of clinically-apparent metastatic disease
Tracking Information
- NCT #
- NCT01322750
- Collaborators
- Bureau of Navy Medicine (BUMED)
- Investigators
- Not Provided
Get Well Soon